231 related articles for article (PubMed ID: 33437186)
1. Secondary immunodeficiencies with predominant antibody deficiency: multidisciplinary perspectives of Polish experts.
Jahnz-RÓŻyk K; WiĘsik-Szewczyk E; RoliŃski J; Siedlar M; JĘdrzejczak W; Sydor W; Tomaszewska A
Cent Eur J Immunol; 2020; 45(3):334-341. PubMed ID: 33437186
[TBL] [Abstract][Full Text] [Related]
2. AAOA allergy primer: immunodeficiency.
Ryan MW
Int Forum Allergy Rhinol; 2014 Sep; 4 Suppl 2():S74-8. PubMed ID: 25182361
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin replacement therapy in secondary hypogammaglobulinemia.
Compagno N; Malipiero G; Cinetto F; Agostini C
Front Immunol; 2014; 5():626. PubMed ID: 25538710
[TBL] [Abstract][Full Text] [Related]
4. Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases.
Ballow M; Sánchez-Ramón S; Walter JE
Front Immunol; 2022; 13():928062. PubMed ID: 35924244
[TBL] [Abstract][Full Text] [Related]
5. The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.
Patel SY; Carbone J; Jolles S
Front Immunol; 2019; 10():33. PubMed ID: 30800120
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.
Compagno N; Cinetto F; Semenzato G; Agostini C
Haematologica; 2014 Jun; 99(6):1101-6. PubMed ID: 24682509
[TBL] [Abstract][Full Text] [Related]
7. Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab.
Mogensen TH; Bernth-Jensen JM; Petersen CC; Petersen MS; Nyvold C; Gadegaard KH; Hokland M; Hokland P; Larsen CS
BMC Hematol; 2013 Apr; 13(1):4. PubMed ID: 24499503
[TBL] [Abstract][Full Text] [Related]
8. Nursing guidelines for administration of immunoglobulin replacement therapy.
Younger ME; Aro L; Blouin W; Duff C; Epland KB; Murphy E; Sedlak D;
J Infus Nurs; 2013; 36(1):58-68. PubMed ID: 23271153
[TBL] [Abstract][Full Text] [Related]
9. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
10. Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.
Gernez Y; Baker MG; Maglione PJ
Transfusion; 2018 Dec; 58 Suppl 3(Suppl 3):3056-3064. PubMed ID: 30536429
[TBL] [Abstract][Full Text] [Related]
11. Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.
Duraisingham SS; Buckland M; Dempster J; Lorenzo L; Grigoriadou S; Longhurst HJ
PLoS One; 2014; 9(6):e100324. PubMed ID: 24971644
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Clinical and Immunological Variables and Humoral Response to SARS-CoV-2 Vaccination in Adult Patients with Antibody Deficiency Disorders.
Bracke C; Miranda C; González S; Casas I; Cardona PJ; Benitez RM; Sopena N; Reynaga EA; Massanella M; Clotet B; Carrillo J; Mateu L; Pedro-Botet ML
Pathogens; 2022 Nov; 11(11):. PubMed ID: 36422615
[TBL] [Abstract][Full Text] [Related]
13. Secondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology.
Szepanowski F; Warnke C; Meyer Zu Hörste G; Mausberg AK; Hartung HP; Kleinschnitz C; Stettner M
CNS Drugs; 2021 Nov; 35(11):1173-1188. PubMed ID: 34657228
[TBL] [Abstract][Full Text] [Related]
14. Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives.
Ar MC; El Fakih R; Gabbassova S; Alhuraiji A; Nasr F; Alsaeed A; Sayinalp N; Marashi M
Leuk Res; 2023 Oct; 133():107365. PubMed ID: 37643508
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic and therapeutic management of increased susceptibility to infection in patients with immunodeficiency].
Hanitsch LG
Internist (Berl); 2022 May; 63(5):484-492. PubMed ID: 35412057
[TBL] [Abstract][Full Text] [Related]
16. [Immunglobulin Substitution Therapy in Hematological Patients with secondary Antibody Deficiency].
Braschler TR; Zeerleder S
Ther Umsch; 2022 Aug; 79(6):295-300. PubMed ID: 35903825
[TBL] [Abstract][Full Text] [Related]
17. When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.
Jolles S; Chapel H; Litzman J
Clin Exp Immunol; 2017 Jun; 188(3):333-341. PubMed ID: 28000208
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Manifestations of Primary Humoral Deficiencies.
Casal A; Riveiro V; Suárez-Antelo J; Ferreiro L; Rodríguez-Núñez N; Lama A; Toubes ME; Valdés L
Can Respir J; 2022; 2022():7140919. PubMed ID: 35440951
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
